Search Research Articles
Browse Research Categories

SS-31 Peptide Research

SS-31 (Szeto-Schiller peptide 31, elamipretide) is a mitochondria-targeted tetrapeptide that selectively concentrates in the inner mitochondrial membrane, where it binds cardiolipin to stabilize cristae architecture, improve electron transport chain efficiency, reduce reactive oxygen species production, and support ATP synthesis. Research has explored its applications in heart failure, ischemia-reperfusion injury, kidney disease, age-related muscle loss, and neurodegeneration — conditions where mitochondrial dysfunction is a central pathological mechanism. SS-31 represents one of the most advanced mitochondria-targeted therapeutic peptides under investigation. This section covers scientific studies on SS-31 and its mitochondrial protection and cellular energy research applications.

Other Popular Research Categories

Newest SS-31 Research

SS-31 Peptide Research – Complete Guide

SS-31, also known as elamipretide or Bendavia, is a synthetic tetrapeptide that selectively accumulates at the inner mitochondrial membrane, where it binds cardiolipin and stabilizes the machinery responsible for ATP production. This article covers SS-31 peptide research across its cardiolipin-binding mechanism, mitochondrial bioenergetics, clinical trial data, and its landmark 2025 FDA approval for Barth syndrome under the brand name Forzinity....

About The Cenexa Labs Research Library

This section of the research library focuses on scientific studies involving and related research. The Cenexa Research Library compiles publicly available scientific literature and research summaries related to peptides, bioregulators, and signaling molecules. Our goal is to make complex scientific research easier to understand without requiring a technical background.
Scroll to Top
0